Stock Price Forecast

Nov. 16, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Athersys Inc chart...

About the Company

athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.

CEO

Gil Van Bokkelen

Exchange

OTC MARKETS

Website

http://www.athersys.com/

$0M

Total Revenue

81

Employees

$0M

Market Capitalization

0.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ATHX News

Athersys Inc ATHXQ

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Why Athersys Shares Are Falling During Tuesday's Session

11mon ago, source: Hosted on MSN

Athersys Inc (NASDAQ: ATHX) shares are trading lower by 12.94% to $0.98 Tuesday morning. The company announced a $3.7 million registered direct offering and concurrent private placement.

Athersys Inc Stock (OTC:ATHX), Insider Trading Activity

1mon ago, source: Benzinga.com

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...

Athersys Stock Rises on Positive Results for Stem Cell Therapy

2y ago, source: TheStreet.com

Athersys partner Healios releases positive results from a trial of its MultiStem cell therapy (invimestrocel) for acute respiratory distress syndrome. Athersys (ATHX) rose sharply Friday after ...

Athersys (ATHXQ) Earnings Dates & Reports

4mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Sweet Baby Inc. Doesn’t Do What Some Gamers Think It Does

23d ago, source: Kotaku

Sweet Baby Inc. is not the largest narrative design company in the games industry. Nor is it solely responsible for the characters and stories in recent high-profile releases like Alan Wake 2 ...

CVM CEL-SCI Corporation

6d ago, source: Seeking Alpha

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States.

Evelo Biosciences, Inc. (EVLO)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

BCLI Brainstorm Cell Therapeutics Inc.

13d ago, source: Seeking Alpha

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Search Results

2mon ago, source: The Business Journals

ABM General Services Inc. has laid off all 127 of its employees who worked at Amazon's fulfillment center in North Randall, Ohio.… United Airlines, in what it said is a first for a major airline ...

Athersys, Inc. (ATHXQ)

2mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...